BRCA1 and breast cancer: The first clinical evidence for the importance of FANCJ was the identification of germ line sequence changes in FANCJ that were associated with early breast cancer in two individuals that displayed normal genotypes for BRCA1 and BRCA2 (Cantor et al., 2001).